A comprehensive view of Celltrion Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

South Korea-based Celltrion announces licensing contract with UN Medicine Patent Pool to manufacture generic version of Pfizer's oral COVID-19 treatment
Published: March 22, 2022 by Asian News International
FDA alerts against using Celltrion's DiaTrust COVID-19 Ag Rapid Tests due to risk of false results; test has not been authorized, cleared or approved by the FDA
Published: March 02, 2022 by ForeignAffairs.co.nz

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count